Tool monitors flu mutations in real time
A new tool can monitor influenza A virus mutations in real time, researchers report.
Regenerative medicine companies raised $4.8B in first half of 2019
Two new approvals, more than 1,000 clinical trials underway and nearly $5 billion raised.